𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The nexus of iron and inflammation in hepcidin regulation: SMADs, STATs, and ECSIT

✍ Scribed by Elizabeth Milward; Daniel Johnstone; Debbie Trinder; Grant Ramm; John Olynyk


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
75 KB
Volume
45
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors.


πŸ“œ SIMILAR VOLUMES


Iron-mediated regulation of liver hepcid
✍ Duygu Dee Harrison-Findik; Elizabeth Klein; Callie Crist; John Evans; Nikolai Ti πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 320 KB

Alcohol reduces and iron increases liver hepcidin synthesis. This study investigates the interaction of alcohol and iron in the regulation of hepcidin messenger RNA (mRNA) expression in animal models. Mice were administered 10% ethanol for 7 days after an iron-overloaded diet. Rats were administered

Distribution of the iron-regulating prot
✍ S. Zechel; K. Huber-Wittmer; Oliver von Bohlen und Halbach πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 585 KB

## Abstract Iron serves as an essential trace element for all body tissues, including the central nervous system (CNS). Because iron deficiency as well as iron overload is known to cause damage to the mammalian brain, the maintenance of iron homeostasis is crucial. It has been discovered recently t

Local activation of STAT-1 and STAT-3 in
✍ Alfons S. K. de Hooge; Fons A. J. van de Loo; Marije I. Koenders; Miranda B. Ben πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 594 KB

## Abstract ## Objective STAT proteins play an important role in cytokine signaling. Some investigators have reported preferential activation of STAT‐1, and others have reported preferential activation of STAT‐3, in response to endogenous interleukin‐6 (IL‐6), in patients with rheumatoid arthritis